MAX Financial Services reported a consolidated net loss of ₹26.35 crores for Q4 FY26, marking a dramatic reversal from the ₹36.56 crores profit recorded in Q3 FY26. According to the latest financial results, the company's total income declined 24.26% quarter-on-quarter to ₹10,805.48 crores from ₹14,267.43 crores in the previous quarter. The earnings per share turned negative at ₹-0.77 compared to ₹1.07 in Q3 FY26. For the full financial year FY26, the company posted a net profit of ₹83.97 crores, down 74.34% from ₹327.21 crores in FY25, with EPS declining to ₹2.45 from ₹9.53 in the previous year.
Despite the quarterly setback, MAX Financial Services delivered impressive annual results with strong annual premium equivalent growth of 31.5% quarter-on-quarter and 18.3% year-on-year, reaching ₹3,590 crore. The company's calculated VNB came in at ₹1,014 crore, representing a 53.9% quarter-on-quarter and 19% year-on-year growth, though it was 4% lower than estimates. The VNB margin for the quarter stood at 28.2%, while the full-year VNB margin was 25.2%, meeting the company's earlier guidance of 24-25% for FY26. The strong year-on-year growth was primarily driven by Annuity business which grew by 179% YoY and individual protection which grew by 52% YoY. For the full year FY26, the APE stood at ₹10,502 crore, up by 19.7% YoY.
The market reacted negatively to the quarterly results, with shares of Max Financial Services trading at ₹1,653.05 on BSE as of the latest session, down from the previous close of ₹1,694.80. The stock hit an intraday high of ₹1,699.95 and intraday low of ₹1,649.20 during the trading session, with total shares traded of 7,350 in over 1,230 trades and net turnover of ₹12,28,32,670. The sharp decline reflects investor concerns over the quarterly loss despite the company's strong annual performance metrics.
Despite a 'Buy' rating and ₹2,100 price target from Systematix, the shortfall in VNB raises questions about margin sustainability. The company's high P/E ratio of 300-400 suggests aggressive growth expectations, making any deviation from projected performance a risk. Other analysts hold more cautious views; HDFC Securities recommends an 'ADD' rating with ₹1,420 target, while Motilal Oswal rates the stock 'Neutral' with ₹1,020 target. Overall analyst sentiment remains positive, with 24 recommending 'Buy' and none suggesting a 'Sell', projecting an average 12-month price target of ₹2,050.56, implying an upside of 24%. However, the company's market capitalization of ₹57,000-₹58,000 crore stands in sharp contrast to peers such as HDFC Life (P/E of 69.4) and ICICI Prudential Life (P/E of 49.8).
Max Financial is exploring strategic initiatives including exploring the amalgamation of the holding company with Axis Max Life for a potential direct listing of the insurance business and a qualified institutional placement to raise up to ₹1,600 crore. The company maintains a strong claim settlement ratio of 99.65% and an asset base of $20.87 billion, though this remains considerably smaller than competitors. The brokerage assumes the company to maintain its VNB margin around the 25% mark going forward, with various factors aiding the company including yield curve benefits and ongoing commission negotiations with distributors. The broader Indian life insurance sector saw 12% growth in FY26, but this expansion relies more on high-value products, as policy volumes grew only 5%, presenting ongoing challenges for sustained growth.
